Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 23, 2024 - Issue 3
Submit an article Journal homepage
253
Views
0
CrossRef citations to date
0
Altmetric
Original Research

A real-world disproportionality analysis of anti-VEGF drugs from the FDA Adverse Event Reporting System

Ruishan Zhoua School of Public Health, Guangdong Pharmaceutical University, Guangzhou, ChinaORCID Iconhttps://orcid.org/0000-0001-5804-8523View further author information
ORCID Icon,
Peiwen Lua School of Public Health, Guangdong Pharmaceutical University, Guangzhou, ChinaView further author information
,
Mingxiu Hea School of Public Health, Guangdong Pharmaceutical University, Guangzhou, ChinaView further author information
,
Junheng Chena School of Public Health, Guangdong Pharmaceutical University, Guangzhou, ChinaView further author information
,
Yiyang Shia School of Public Health, Guangdong Pharmaceutical University, Guangzhou, ChinaView further author information
,
Fangfang Hanb School of Medical Information and Engineering, Guangdong Pharmaceutical University, Guangzhou, China;c NMPA Key Laboratory for Technology Research and Evaluation of Pharmacovigilance, Guangzhou, ChinaCorrespondence[email protected]
View further author information
&
Yongming Caib School of Medical Information and Engineering, Guangdong Pharmaceutical University, Guangzhou, China;c NMPA Key Laboratory for Technology Research and Evaluation of Pharmacovigilance, Guangzhou, China;d Guangdong Provincial Traditional Chinese Medicine Precision Medicine Big Data Engineering Technology Research Center, Guangzhou, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 363-371 | Received 26 Feb 2023, Accepted 10 Jul 2023, Published online: 04 Sep 2023

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.